P2RX7 and neoplasm: Interestingly, the tumor infiltrate of P2X7 null bearing mice treated with A740003 was characterized by increased CD4+ levels (Fig. 7f) and decreased expression of CD73 on both Treg and Teff cells (Fig. 7g, h), possibly due to factors released by tumor cells following P2X7 blockade.